What is the CHA2DS2‑VASc score for a 71‑year‑old man with no other comorbidities who has had a single prior stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CHA₂DS₂-VASc Score Calculation

The correct answer is C. 3 points.

Score Breakdown

For this 71-year-old male with a history of stroke and no other comorbidities, the CHA₂DS₂-VASc score is calculated as follows:

  • Age 65-74 years: 1 point 1
  • Prior stroke: 2 points 1
  • Male sex: 0 points 1
  • All other components (congestive heart failure, hypertension, diabetes, vascular disease): 0 points 1

Total score: 3 points 1

Important Clarification on Age Scoring

A critical distinction exists between the older CHADS₂ and newer CHA₂DS₂-VASc scoring systems regarding age:

  • CHADS₂ score: Awards 1 point only for age ≥75 years 2
  • CHA₂DS₂-VASc score: Awards 1 point for age 65-74 years AND 2 points for age ≥75 years 3, 1

Since this patient is 71 years old, he receives 1 point for age under CHA₂DS₂-VASc (not 0 points as would be the case with CHADS₂) 1.

Clinical Significance

A CHA₂DS₂-VASc score of 3 indicates high stroke risk, with an annual stroke rate of approximately 3.2-5.3% without anticoagulation 3. This score mandates oral anticoagulation therapy 3.

Anticoagulation Recommendation

  • Oral anticoagulation is strongly recommended (Class I indication) for any patient with CHA₂DS₂-VASc score ≥2 3, 1
  • Direct oral anticoagulants (DOACs) are preferred over warfarin as first-line therapy 1
  • If warfarin is used, maintain INR 2.0-3.0 with time in therapeutic range >70% 1

Common Pitfall

The most frequent error in this scenario is misapplying CHADS₂ age criteria to CHA₂DS₂-VASc scoring 2. Clinicians may incorrectly assign 0 points for age <75 years, yielding an incorrect total of 2 points instead of 3 points 2. This distinction is clinically meaningful because it affects risk stratification and reinforces the indication for anticoagulation 3.

References

Guideline

CHA₂DS₂-VASc Risk Stratification for Atrial Fibrillation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

CHADS₂ Scoring System and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

How do you assess high thromboembolic risk in a patient?
What is the CHADS2 (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, Stroke or transient ischemic attack) score for a patient with atrial fibrillation, congestive heart failure, hypertension, diabetes mellitus, and a history of stroke, presenting with dyspnea, shortness of breath, palpitations, irregular pulse, high jugular venous pressure (JVP), S3 heart sound, bi-basal crackles, tachycardia, and hypoxemia?
What is the scoring system for new thrombocytopenia using the CHADVASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score?
What is the CH2DS2-VASc (Congestive heart failure, Hypertension, 2 points for age ≥75 years, Diabetes, Stroke/Transient ischemic attack/thromboembolism, Vascular disease, Age 65-74 years, Sex category) score for an older male, ≥75 years, with a history of stroke, but otherwise medically free?
How do I calculate a patient's CHA2DS2-VASc (Congestive Heart Failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or Transient Ischemic Attack, Vascular disease, Age 65-74 years, Sex category) score?
How should I manage a patient presenting with heel‑spur pain?
What are the clinical stages of scalp discoid lupus erythematosus, the diagnostic criteria for this condition, and the signs that indicate active versus stable disease?
How effective is citalopram for treating obsessive‑compulsive disorder in adults, and what are the recommended dose and trial duration?
How should I wean a hemodynamically stable adult on mechanical ventilation who is on minimal vasopressor support, has adequate oxygenation with FiO2 (fraction of inspired oxygen) ≤0.40, PEEP (positive end‑expiratory pressure) ≤5 cm H2O (PaO2/FiO2 >200 mm Hg), is normothermic, awake, able to protect his airway, and can initiate spontaneous breaths?
What is probenecid and why should it be given before cefazolin?
What is the preferred initial treatment for an isolated left axillary furuncle in a healthy adult without systemic signs?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.